# Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection

> **NCT01535209** · PHASE3 · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 100 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** stereotactic body radiotherapy (SBRT)
- **RADIATION:** Whole-Brain Radiotherapy (WBRT)

## Key facts

- **NCT ID:** NCT01535209
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535209, "Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01535209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*